Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390793
Status:
COMPLETED
Last Update Posted:
2024-02-07
First Post:
2006-10-18
Brief Title:
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-18
First Submit QC Date:
October 19 2006
Study First Post Date:
2006-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-06
Last Update Post Date:
2024-02-07
Last Update Post Date Type:
ACTUAL